The CAIRP (CAndesartan for in-stent restenosis prevention) trial - A multicenter study of AT1-receptor blocker therapy in coronary stenting

Journal of Invasive Cardiology

Volumn 20, Issue 5, 2008, Pages 205-210

  Krämer, Jochen ^c   Ruf, Rainer G ^a   Schmidt, Sibylle ^a   Axthelm, Christoph ^d   Strasser, Ruth ^e   Janssen, Gerhard ^f   Thieme, Torsten ^g   Kusch, Angelika ^a   Waigand, Jürgen ^b   Dietz, Rainer ^a,b   Gross, C Michael ^a,h  

^a FRANZ VOLHARD CLINIC   (Germany)

^b Campus Virchow Clinic ^*

^c Interventional Cardiology Spandau

^d MARTIN LUTHER KRANKENHAUS   (Germany)

^e UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^f Department of Cardiology and Angiology

^g UNFALLKRANKENHAUS BERLIN   (Germany)

^h Helios Klinikum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE RECEPTOR BLOCKING AGENT; CANDESARTAN HEXETIL; PLACEBO;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DOUBLE BLIND PROCEDURE; DRUG FATALITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; THROMBOSIS; UNSPECIFIED SIDE EFFECT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; BLOOD VESSEL PROSTHESIS IMPLANTATION; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DOUBLE-BLIND METHOD; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLACEBOS; PROSPECTIVE STUDIES; TETRAZOLES; TREATMENT OUTCOME;

EID: 43149100121     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (35)